Showing results (391-400 of 876) with videos related to

Sort By:
Pageof 88
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1990
Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylaseJ D McDonald, V C Bode, W F Dove, et al.
Genetics|February 1, 1988
hph-1: a mouse mutant with hereditary hyperphenylalaninemia induced by ethylnitrosourea mutagenesisV C Bode, J D McDonald, J L Guenet, et al.
Thrombosis and Haemostasis|March 1, 2000
Plasminogen activator inhibitor type-1 (PAI-1) and its role in cardiovascular diseaseT K Nordt, K Peter, J Ruef, et al.
Thrombosis and Haemostasis|March 1, 2000
Pharmacokinetics and pharmacodynamics of lanoteplase (n-PA)T K Nordt, M Moser, B Kohler, et al.
Zeitschrift Fur Kardiologie|January 1, 1993
Combinations of thrombolytic agents in acute myocardial infarctionC Bode, H Baumann, E von Hodenberg, et al.
Klinische Wochenschrift|October 3, 1990
Gastric emptying in non-responders to H2-receptor antagonistsS Walker, J Meinke, U Klotz, et al.
Deutsche Medizinische Wochenschrift (1946)|February 21, 1986
[Vipoma. 9-year observations using currently available therapy methods]K Zimmermann, T Rapp, J Binder, et al.
Zeitschrift Fur Kardiologie|February 6, 2002
[Myocardial revascularization after pretreatment with the GPIIb/IIIa receptor blocker abciximab]C F Vahl, N Kayhan, G Thomas, et al.
Methods and Findings in Experimental and Clinical Pharmacology|October 1, 1993
Ocular effects of topical administration of the phosphodiesterase III inhibitor milrinone in rabbits and catsK C Lee, P J Silver, D C Bode, et al.
Pageof 88